As filed with the Securities and Exchange Commission on February 12, 2026. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 MOVANO INC. (Exact name of registrant as specified in its charter) incorporation or organization) Classification Code Number) Identification No.) (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer Delaware 3845 82-4233771 6800 Koll Center Parkway Pleasanton, CA 94566 (415) 651-3172 AMENDMENT NO. 1 to FORM S-1 REGISTRATION STATEMENT UNDE ...

As filed with the Securities and Exchange Commission on February 9, 2026. Registration No. 333- 292322 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOVANO INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification No.) 6800 Koll Center Parkway Plea ...

As filed with the Securities and Exchange Commission on January 13, 2026. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 3845 82-4233771 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification No.) 6800 Koll Center Parkway Pleasanton, CA 94566 (415) ...

Core Points - Movano Health has received approval from the Nasdaq Hearings Panel to continue its listing on Nasdaq, contingent upon regaining compliance with specific listing rules by set deadlines [1][2] - The company must file its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, and June 30, 2025, by September 30, 2025, and maintain a bid price of at least $1.00 per share by October 30, 2025 [1][2] - Movano Health is actively working with a new auditor to complete the necessary filings and has filed a Preliminary Proxy Statement for a reverse stock split proposal to help meet the bid price requirement [2] Company Overview - Movano Health, founded in 2018, focuses on developing healthcare solutions that provide medical-grade data through wearable devices [3] - The company's flagship product, the Evie Ring, aims to deliver personalized health insights by capturing comprehensive health data [3][4] - Movano Health's proprietary technologies are designed to proactively monitor and manage health outcomes across various patient populations [4]

Core Viewpoint - Movano Health has initiated a process to explore strategic alternatives, including a potential sale or merger, to maximize shareholder value [1]. Company Overview - Movano Health, founded in 2018, is focused on developing healthcare solutions that provide medical-grade data through wearable technology [3]. - The company's devices are designed to deliver trusted health data and insights, capturing a comprehensive picture of individual health [3][4]. Strategic Actions - The Board of Directors has engaged Aquilo Partners as a financial advisor and K&L Gates LLP as legal counsel to assist in exploring strategic alternatives [1]. - There is no assurance that this process will lead to a transaction or strategic change, and the company does not plan to disclose further developments until a specific course of action is approved [2]. Financial Reporting - Movano Health has indicated that due to resource constraints, it will not timely file its quarterly report on Form 10-Q for the quarter ended March 31, 2025 [2].

Core Insights - Movano Health has announced new features for the Evie Ring's companion app, enhancing support for women's wellness journeys through data personalization and trend tracking [1][2] - The Evie Ring is priced at $269 with no subscription fees, making it accessible for users, and is eligible for HSA/FSA reimbursement [2] Product Features - Integration with Apple Health allows automatic import of Evie data, enabling users to view information from both platforms in one location [5] - The app now includes 7- and 30-day trend graphs for sleep metrics, helping users understand their health patterns over time [5] - Daily basal body temperature logging has been added to assist users in tracking their menstrual cycles [5] - Heart rate mapping provides a visual representation of users' heart rates throughout the day, categorized by activity levels [5] - The expansion of workout tracking allows users to manually log past workouts, ensuring they receive credit for calories burned [5] - The Daily Summary home screen now includes menstrual cycle day and phase, enhancing the app's one-stop value for tracking health metrics [5] Company Overview - Movano Health, founded in 2018, focuses on developing healthcare solutions that provide medical-grade data through wearables [3] - The company's Evie and EvieMED devices aim to deliver trusted health data and personalized insights to users [3]